NR2A and NR2B subunit containing NMDA receptors differentially regulate striatal output pathways

Journal of Neurochemistry

Volumn 103, Issue 6, 2007, Pages 2200-2211

  Fantin, Martina ^a   Marti, Matteo ^a   Auberson, Yves P ^b   Morari, Michele ^a  

^a UNIVERSITY OF FERRARA   (Italy)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

GABA; Glutamate; Microdialysis; NMDA; NVP AAM077; Ro 25 6981

Indexed keywords

1 (4 BROMO PHENYL) ETHYLAMINO (2,3 DIOXO 1,2,3,4 TETRAHYDROQUINOXALIN 5 YL) METHYL PHOSPHORIC ACID; 4 BENZYL ALPHA (4 HYDROXYPHENYL) BETA METHYL 1 PIPERIDINEPROPANOL; IONOTROPIC RECEPTOR ANTAGONIST; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2A; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 2B; PROTEIN SUBUNIT; TETRODOTOXIN; UNCLASSIFIED DRUG;

4 AMINOBUTYRIC ACID RELEASE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; EVOKED RESPONSE; GLOBUS PALLIDUS; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; STRIATE CORTEX; SUBSTANTIA NIGRA;

ANIMALS; EFFERENT PATHWAYS; EXCITATORY AMINO ACID ANTAGONISTS; EXTRACELLULAR FLUID; GABA AGONISTS; GAMMA-AMINOBUTYRIC ACID; GLOBUS PALLIDUS; GLUTAMIC ACID; MALE; MICRODIALYSIS; NEOSTRIATUM; NEURAL INHIBITION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; SODIUM CHANNEL BLOCKERS; SUBSTANTIA NIGRA; SYNAPTIC TRANSMISSION;

EID: 36448964885     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.04966.x     Document Type: Article

References (60)

1. Albin R. L., Young A. B. Penney J. B. (1989) The functional anatomy of basal ganglia disorders. Trends Neurosci. 12, 366 375.
2. Alexander G. E. Crutcher M. D. (1990) Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 13, 266 271.
3. Auberson Y. P., Allgeier H., Bischoff S., Lingenhoehl K., Moretti R. Schmutz M. (2002) 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition. Bioorg. Med. Chem. Lett. 12, 1099 1102.
4. Bartlett T. E., Bannister N. J., Collett V. J., Dargan S. L., Massey P. V., Bortolotto Z. A., Fitzjohn S. M., Bashir Z. I., Collingridge G. L. Lodge D. (2007) Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus. Neuropharmacology 52, 60 70.
5. Berberich S., Punnakkal P., Jensen V., Pawlak V., Seeburg P. H., Hvalby O. Kohr G. (2005) Lack of NMDA receptor subtype selectivity for hippocampal long-term potentiation. J. Neurosci. 25, 6907 6910.
6. Cai N. S., Kiss B. Erdo S. L. (1991) Heterogeneity of N-methyl-D-aspartate receptors regulating the release of dopamine and acetylcholine from striatal slices. J. Neurochem. 57, 2148 2151.
7. Chaperon F., Müller W., Auberson Y. P., Tricklebank M. D. Neijt H. C. (2003) Substitution for PCP, disruption of prepulse inhibition and hyperactivity induced by N-methyl-D-aspartate receptor antagonists: preferential involvement of the NR2B rather than NR2A subunit. Behav. Pharmacol. 14, 477 487.
8. Chase T. N. Oh J. D. (2000) Striatal mechanisms and pathogenesis of parkinsonian signs and motor complications. Ann. Neurol. 47, S122 S129.
9. Chevalier G. Deniau J. M. (1990) Disinhibition as a basic process in the expression of striatal functions. Trends Neurosci. 13, 277 280.
10. DeLong M. R. (1990) Primate models of movement disorders of basal ganglia origin. Trends Neurosci. 13, 281 285.
11. Di Chiara G., Morelli M. Consolo S. (1994) Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci. 17, 228 233.
12. Dingledine R., Borges K., Bowie D. Traynelis S. F. (1999) The glutamate receptor ion channels. Pharmacol. Rev. 51, 7 61.
13. Dunah A. W. Standaert D. G. (2003) Subcellular segregation of distinct heteromeric NMDA glutamate receptors in the striatum. J. Neurochem. 85, 935 943.
14. Dunah A. W., Wang Y., Yasuda R. P., Kameyama K., Huganir R. L., Wolfe B. B. Standaert D. G. (2000) Alterations in subunit expression, composition, and phosphorylation of striatal N-methyl-D-aspartate glutamate receptors in a rat 6-hydroxydopamine model of Parkinson's disease. Mol. Pharmacol. 57, 342 352.
15. Fantin M., Fischetti C., Ballini C., Della Corte L., Marti M. Morari M. (2005) Striatal NMDA receptors regulate the striato-pallidal pathway. Proc. Natl Congr. Italian Soc. Neurosci. 654.
16. Feng B., Tse H. W., Skifter D. A., Morley R., Jane D. E. Monaghan D. T. (2004) Structure-activity analysis of a novel NR2C/NR2D-preferring NMDA receptor antagonist: 1-(phenanthrene-2-carbonyl) piperazine-2,3-dicarboxylic acid. Br. J. Pharmacol. 141, 508 516.
17. Fiorentini C., Rizzetti M. C., Busi C., Bontempi S., Collo G., Spano P. Missale C. (2006) Loss of synaptic D1 dopamine/N-methyl-D-aspartate glutamate receptor complexes in L-DOPA-induced dyskinesia in the rat. Mol. Pharmacol. 69, 805 812.
18. Fischer G., Mutel V., Trube G., Malherbe P., Kew J. N., Mohacsi E., Heitz M. P. Kemp J. A. (1997) Ro 25-6981, a highly potent and selective blocker of N-methyl-D-aspartate receptors containing the NR2B subunit. Characterization in vitro. J. Pharmacol. Exp. Ther. 283, 1285 1292.
19. Fox C. J., Russell K. I., Wang Y. T. Christie B. R. (2006) Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo. Hippocampus 16, 907 915.
20. Frizelle P. A., Chen P. E. Wyllie D. J. (2006) Equilibrium constants for (R)-[(S)-1-(4-bromo-phenyl)-ethylamino]-(2,3-dioxo-1,2,3,4-tetrahydroquino xalin-5-yl)-methyl]-phosphonic acid (NVP-AAM077) acting at recombinant NR1/NR2A and NR1/NR2B N-methyl-D-aspartate receptors: implications for studies of synaptic transmission. Mol. Pharmacol. 70, 1022 1032.
21. Ganguly A. Keefe K. A. (2001) Unilateral dopamine depletion increases expression of the 2A subunit of the N-methyl-D-aspartate receptor in enkephalin-positive and enkephalin-negative neurons. Neuroscience 103, 405 412.
22. Hallett P. J. Standaert D. G. (2004) Rationale for and use of NMDA receptor antagonists in Parkinson's disease. Pharmacol. Ther. 102, 155 174.
23. Ishii T., Moriyoshi K., Sugihara H. et al. (1993) Molecular characterization of the family of the N-methyl-D-aspartate receptor subunits. J. Biol. Chem. 268, 2836 2843.
24. Klockgether T. Turski L. (1993) Toward an understanding of the role of glutamate in experimental parkinsonism: agonist-sensitive sites in the basal ganglia. Ann. Neurol. 34, 585 593.
25. Koós T. Tepper J. M. (1999) Inhibitory control of neostriatal projection neurons by GABAergic interneurons. Nat. Neurosci. 2, 467 472.
26. Landwehrmeyer G. B., Standaert D. G., Testa C. M., Penney J. B. Jr. Young A. B. (1995) NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J. Neurosci. 15, 5297 5307.
27. Laurie D. J. Seeburg P. H. (1994) Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit composition. Eur. J. Pharmacol. 268, 335 345.
28. Liu L., Wong T. P., Pozza M. F., Lingenhoehl K., Wang Y., Sheng M., Auberson Y. P. Wang Y. T. (2004) Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity. Science 304, 1021 1024.
29. Mallon A. P., Auberson Y. P. Stone T. W. (2005) Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D-aspartate receptors in hippocampal slices. Exp. Brain Res. 162, 374 383.
30. Marti M., Sbrenna S., Fuxe K., Bianchi C., Beani L. Morari M. (2000) Increased responsivity of glutamate release from the substantia nigra pars reticulata to striatal NMDA receptor blockade in a model of Parkinson's disease. A dual probe microdialysis study in hemiparkinsonian rats. Eur. J. Neurosci. 12, 1848 1850.
31. Marti M., Mela F., Bianchi C., Beani L. Morari M. (2002) Striatal dopamine-NMDA receptor interactions in the modulation of glutamate release in the substantia nigra pars reticulata in vivo: opposite role for D1 and D2 receptors. J. Neurochem. 83, 635 644.
32. Marti M., Paganini F., Stocchi S., Mela F., Beani L., Bianchi C. Morari M. (2003) Plasticity of glutamatergic control of striatal acetylcholine release in experimental parkinsonism: opposite changes at group-II metabotropic and NMDA receptors. J. Neurochem. 84, 792 802.
33. Marti M., Manzalini M., Fantin M., Bianchi C., Della Corte L. Morari M. (2005) Striatal glutamate release evoked in vivo by NMDA is dependent upon ongoing neuronal activity in the substantia nigra, endogenous striatal substance P and dopamine. J. Neurochem. 93, 195 205.
34. Massey P. V., Johnson B. E., Moult P. R., Auberson Y. P., Brown M. W., Molnar E., Collingridge G. L. Bashir Z. I. (2004) Differential roles of NR2A and NR2B-containing NMDA receptors in cortical long-term potentiation and long-term depression. J. Neurosci. 24, 7821 7828.
35. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanishi T., Arakawa M., Sakimura K. Mishina M. (1992) Functional characterization of a heteromeric NMDA receptor channel expressed from cloned cDNAs. Nature 357, 70 74.
36. Miyamoto Y., Yamada K., Noda Y., Mori H., Mishina M. Nabeshima T. (2001) Hyperfunction of dopaminergic and serotonergic neuronal systems in mice lacking the NMDA receptor epsilon1 subunit. J. Neurosci. 21, 750 757.
37. Monaghan D. T. Cotman C. W. (1985) Distribution of N-methyl-D-aspartate- sensitive L-[3H]glutamate-binding sites in rat brain. J. Neurosci. 5, 2909 2919.
38. Monyer H., Sprengel R., Schoepfer R., Herb A., Higuchi M., Lomeli H., Burnashev N., Sakmann B. Seeburg P. H. (1992) Heteromeric NMDA receptors: molecular and functional distinction of subtypes. Science 256, 1217 1221.
39. Morari M., O'Connor W. T., Ungerstedt U., Bianchi C. Fuxe K. (1996) Functional neuroanatomy of the nigrostriatal and striatonigral pathways as studied with dual probe microdialysis in the awake rat-II. Evidence for striatal N-methyl-D-aspartate receptor regulation of striatonigral GABAergic transmission and motor function. Neuroscience 72, 89 97.
40. Morari M., Marti M., Sbrenna S., Fuxe K., Bianchi C. Beani L. (1998a) Reciprocal dopamine-glutamate modulation of release in the basal ganglia. Neurochem. Int. 33, 383 397.
41. Morari M., Sbrenna S., Marti M., O'Connor W. T., Bianchi C., Fuxe K. Beani L. (1998b) Evidence for a striatal NMDA receptor modulation of nigral glutamate release. A dual probe microdialysis study in the awake freely moving rat. Eur. J. Neurosci. 10, 1716 1722.
42. Murray F., Harrison N. J., Grimwood S., Bristow L. J. Hutson P. H. (2007) Nucleus accumbens NMDA receptor subunit expression and function is enhanced in morphine-dependent rats. Eur. J. Pharmacol. 562, 191 197.
43. Mutel V., Buchy D., Klingelschmidt A., Messer J., Bleuel Z., Kemp J. A. Richards J. G. (1998) In vitro binding properties in rat brain of [3H]Ro 25-6981, a potent and selective antagonist of NMDA receptors containing NR2B subunits. J. Neurochem. 70, 2147 2155.
44. Nakanishi S. (1992) Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597 603.
45. Nankai M., Klarica M., Fage D. Carter C. (1996) Evidence for native NMDA receptor subtype pharmacology as revealed by differential effects on the NMDA-evoked release of striatal neuromodulators: eliprodil, ifenprodil and other native NMDA receptor subtype selective compounds. Neurochem. Int. 29, 529 542.
46. Nash J. E. Brotchie J. M. (2002) Characterisation of striatal NMDA receptors involved in the generation of parkinsonian symptoms: intrastriatal microinjection studies in the 6-OHDA-lesioned rat. Mov. Disord. 17, 455 466.
47. Neyton J. Paoletti P. (2006) Relating NMDA receptor function to receptor subunit composition: limitations of the pharmacological approach. J. Neurosci. 26, 1331 1333.
48. Ossowska K. Wolfarth S. (1995) Stimulation of glutamate receptors in the intermediate/caudal striatum induces contralateral turning. Eur. J. Pharmacol. 273, 89 97.
49. Paxinos G. Watson C. (1982) The rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
50. Schenberg E. E., Ferreira T. L., Figueredo L. Z., Hipolide D. C., Nobrega J. N. Oliveira M. G. (2006) Fear conditioning performance and NMDA receptor subtypes: NR2A differential expression in the striatum. Brain Res. Bull. 69, 440 446.
51. Schmidt W. J. Bury D. (1988) Behavioural effects of N-methyl-D-aspartate in the anterodorsal striatum of the rat. Life Sci. 43, 545 549.
52. Smith Y. Kieval J. Z. (2000) Anatomy of the dopamine system in the basal ganglia. Trends Neurosci. 23, S28 S33.
53. Standaert D. G., Testa C. M., Young A. B. Penney J. B. Jr. (1994) Organization of N-methyl-D-aspartate glutamate receptor gene expression in the basal ganglia of the rat. J. Comp. Neurol. 343, 1 16.
54. Standaert D. G., Testa C. M., Rudolf G. D. Hollingsworth Z. R. (1996) Inhibition of N-methyl-D-aspartate glutamate receptor subunit expression by antisense oligonucleotides reveals their role in striatal motor regulation. J. Pharmacol. Exp. Ther. 276, 342 352.
55. Standaert D. G., Friberg I. K., Landwehrmeyer G. B., Young A. B. Penney J. B. Jr. (1999) Expression of NMDA glutamate receptor subunit mRNAs in neurochemically identified projection and interneurons in the striatum of the rat. Brain Res. 64, 11 23.
56. Thanos P. K., Jhamandas K. Beninger R. J. (1992) N-methyl-D-aspartate unilaterally injected into the dorsal striatum of rats produces contralateral circling: antagonism by 2-amino-7-phosphonoheptanoic acid and cis-flupenthixol. Brain Res. 589, 55 61.
57. West A. R., Moore H. Grace A. A. (2002) Direct examination of local regulation of membrane activity in striatal and prefrontal cortical neurons in vivo using simultaneous intracellular recording and microdialysis. J. Pharmacol. Exp. Ther. 301, 867 877.
58. Yang J., Woodhall G. L. Jones R. S. (2006) Tonic facilitation of glutamate release by presynaptic NR2B-containing NMDA receptors is increased in the entorhinal cortex of chronically epileptic rats. J. Neurosci. 26, 406 410.
59. Yoshida Y., Ono T., Kizu A., Fukushima R. Miyagishi T. (1991) Striatal N-methyl-D-aspartate receptors in haloperidol-induced catalepsy. Eur. J. Pharmacol. 203, 173 180.
60. Zhou M. Baudry M. (2006) Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors. J. Neurosci. 26, 2956 2963.